These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 21133819

  • 1. New therapeutic targets for amyotrophic lateral sclerosis.
    Kuzma-Kozakiewicz M, Kwiecinski H.
    Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
    [Abstract] [Full Text] [Related]

  • 2. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life.
    Brooks BR.
    Ann Neurol; 2009 Jan; 65 Suppl 1():S17-23. PubMed ID: 19191306
    [Abstract] [Full Text] [Related]

  • 3. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C, Frattaroli D, Maura G, Marcoli M.
    Toxicology; 2013 Sep 06; 311(1-2):69-77. PubMed ID: 23583883
    [Abstract] [Full Text] [Related]

  • 4. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R, Nasr-Esfahani MH, Mousavi SA, Basiri K.
    J Clin Neurosci; 2013 Dec 06; 20(12):1659-63. PubMed ID: 24148693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New therapy options for amyotrophic lateral sclerosis.
    Gordon P, Corcia P, Meininger V.
    Expert Opin Pharmacother; 2013 Oct 06; 14(14):1907-17. PubMed ID: 23855817
    [Abstract] [Full Text] [Related]

  • 8. [Amyotrophic lateral sclerosis--electrophysiologic aspects of its pathophysiology and new therapeutic options].
    Kuwabara S.
    Brain Nerve; 2010 Aug 06; 62(8):885-91. PubMed ID: 20714037
    [Abstract] [Full Text] [Related]

  • 9. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement?
    Silani V, Calzarossa C, Cova L, Ticozzi N.
    CNS Neurol Disord Drug Targets; 2010 Jul 06; 9(3):314-24. PubMed ID: 20406179
    [Abstract] [Full Text] [Related]

  • 10. Neurotrophic factors and amyotrophic lateral sclerosis.
    Ekestern E.
    Neurodegener Dis; 2004 Jul 06; 1(2-3):88-100. PubMed ID: 16908980
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM, Boulis NM.
    Neurosci Lett; 2012 Oct 11; 527(2):78-84. PubMed ID: 22579818
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Excitotoxicity and amyotrophic lateral sclerosis.
    Van Damme P, Dewil M, Robberecht W, Van Den Bosch L.
    Neurodegener Dis; 2005 Oct 11; 2(3-4):147-59. PubMed ID: 16909020
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antisense oligonucleotide therapies for Amyotrophic Lateral Sclerosis: Existing and emerging targets.
    Klim JR, Vance C, Scotter EL.
    Int J Biochem Cell Biol; 2019 May 11; 110():149-153. PubMed ID: 30904737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.